Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
Walker AM, Koro CE, Landon J. Walker AM, et al. Among authors: koro ce. Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):760-8. doi: 10.1002/pds.1598. Pharmacoepidemiol Drug Saf. 2008. PMID: 18383443
The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE, Sowell MO, Stender M, Qizilbash N. Koro CE, et al. Clin Ther. 2008 Mar;30(3):535-42. doi: 10.1016/j.clinthera.2008.02.008. Clin Ther. 2008. PMID: 18405791
Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.
Koro CE, Lee BH, Bowlin SJ. Koro CE, et al. Clin Ther. 2009 Nov;31(11):2608-17. doi: 10.1016/j.clinthera.2009.10.020. Clin Ther. 2009. PMID: 20110005
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
Osei SY, Koro CE, Cobitz AR, Kolatkar NS, Stender M. Osei SY, et al. Among authors: koro ce. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1244-6. doi: 10.1002/pds.1840. Pharmacoepidemiol Drug Saf. 2009. PMID: 19655316 No abstract available.
An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients.
Koro CE, Fu Q, Stender M. Koro CE, et al. Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):989-96. doi: 10.1002/pds.1640. Pharmacoepidemiol Drug Saf. 2008. PMID: 18759378
The incidence of congestive heart failure associated with antidiabetic therapies.
Nichols GA, Koro CE, Gullion CM, Ephross SA, Brown JB. Nichols GA, et al. Among authors: koro ce. Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):51-7. doi: 10.1002/dmrr.480. Diabetes Metab Res Rev. 2005. PMID: 15386819
Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE, Bowlin SJ, Weiss SR. Koro CE, et al. Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):697-703. doi: 10.1002/pds.1069. Pharmacoepidemiol Drug Saf. 2005. PMID: 15654719
The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD. Johannes CB, et al. Among authors: koro ce. Pharmacoepidemiol Drug Saf. 2007 May;16(5):504-12. doi: 10.1002/pds.1356. Pharmacoepidemiol Drug Saf. 2007. PMID: 17245800
The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K. Ziyadeh N, et al. Among authors: koro c. Clin Ther. 2009 Nov;31(11):2665-77. doi: 10.1016/j.clinthera.2009.11.003. Clin Ther. 2009. PMID: 20110009
Studies of diabetes, thiazolidinediones, and coronary heart disease.
Walker AM, McAfee AT, Koro C. Walker AM, et al. Among authors: koro c. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1313-4; author reply 1314-6. doi: 10.1002/pds.1498. Pharmacoepidemiol Drug Saf. 2007. PMID: 18041104 No abstract available.
29 results
Jump to page
Feedback